CSIR-NBRI transfer herbal Curcumin technology to Hyderabad firm

Published on:

Lucknow, Oct 26 (IANS) The CSIR-National Botanical Research Institute (NBRI) in Lucknow has transferred the technology for Croma-3, edible capsules of Curcumin, to a Hyderabad-based firm.

Herbal Curcumin is the main active component of turmeric.

“This technology was developed in 2022 and had already been transferred to a company. Now, we are licensing this technology to another Hyderabad-based company named M/s Xavier Med Pvt Ltd for better availability in the market,” said B N Singh, principal scientist, CSIR-NBRI, and the brain behind the Curcumin capsule.

“This herbal formulation contains more than 10 per cent Curcumin, which strengthens the body’s immune system and reduces oxidative stress of the cells. This formulation was developed as per the guidelines of the AYUSH ministry,” he added.

“CSIR-NBRI prepared a formulation with better bioavailability and medicinal properties,” said institute director Ajit Kumar Shasany.

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

Except for the headline and photo, this story has not been edited by THIP Media staff and is published from a syndicated feed / newswire service.